1. Home
  2. BSLK vs ICU Comparison

BSLK vs ICU Comparison

Compare BSLK & ICU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BSLK
  • ICU
  • Stock Information
  • Founded
  • BSLK 2009
  • ICU 2018
  • Country
  • BSLK United States
  • ICU United States
  • Employees
  • BSLK N/A
  • ICU N/A
  • Industry
  • BSLK
  • ICU Biotechnology: Pharmaceutical Preparations
  • Sector
  • BSLK
  • ICU Health Care
  • Exchange
  • BSLK NYSE
  • ICU Nasdaq
  • Market Cap
  • BSLK 12.3M
  • ICU 10.4M
  • IPO Year
  • BSLK N/A
  • ICU N/A
  • Fundamental
  • Price
  • BSLK $2.61
  • ICU $0.42
  • Analyst Decision
  • BSLK
  • ICU
  • Analyst Count
  • BSLK 0
  • ICU 0
  • Target Price
  • BSLK N/A
  • ICU N/A
  • AVG Volume (30 Days)
  • BSLK 1.6M
  • ICU 15.9M
  • Earning Date
  • BSLK 08-21-2025
  • ICU 08-12-2025
  • Dividend Yield
  • BSLK N/A
  • ICU N/A
  • EPS Growth
  • BSLK N/A
  • ICU N/A
  • EPS
  • BSLK N/A
  • ICU N/A
  • Revenue
  • BSLK $1,525,000.00
  • ICU $428,000.00
  • Revenue This Year
  • BSLK N/A
  • ICU $754.07
  • Revenue Next Year
  • BSLK N/A
  • ICU $100.09
  • P/E Ratio
  • BSLK N/A
  • ICU N/A
  • Revenue Growth
  • BSLK N/A
  • ICU N/A
  • 52 Week Low
  • BSLK $1.75
  • ICU $0.31
  • 52 Week High
  • BSLK $340.40
  • ICU $13.85
  • Technical
  • Relative Strength Index (RSI)
  • BSLK N/A
  • ICU 18.81
  • Support Level
  • BSLK N/A
  • ICU $0.31
  • Resistance Level
  • BSLK N/A
  • ICU $0.67
  • Average True Range (ATR)
  • BSLK 0.00
  • ICU 0.12
  • MACD
  • BSLK 0.00
  • ICU -0.08
  • Stochastic Oscillator
  • BSLK 0.00
  • ICU 11.55

About BSLK BOLT PROJECTS HOLDINGS INC

Bolt Projects Holdings Inc develops and produces biomaterials products. Its flagship products from its Vegan Silk Technology Platform, b-silk and xl-silk, are a biodegradable and vegan protein polymer and a replacement for silicone elastomers in beauty and personal care.

About ICU SeaStar Medical Holding Corporation

SeaStar Medical Holding Corp is a medical technology company developing proprietary solutions to reduce the consequences of hyperinflammation on vital organs. It is developing and commercializing extracorporeal therapies that target the effector cells that drive systemic inflammation, causing direct tissue damage and secreting a range of pro-inflammatory cytokines that initiate and propagate imbalanced immune responses.

Share on Social Networks: